Vontobel Swiss Wealth Advisors’s AbbVie ABBV Stock Holding History

Vontobel Swiss Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$442K	Buy	3,923 +225	+6%	+$25.3K	0.23%	54
2021 Q1	$400K	Sell	3,698 -14,294	-79%	-$1.53M	0.22%	52
2020 Q4	$1.93M	Buy	17,992 +6,967	+63%	+$670K	1.1%	23
2020 Q3	$965K	Sell	11,025 -16,502	-60%	-$1.55M	0.67%	32
2020 Q2	$2.7M	Sell	27,527 -3,746	-12%	-$330K	1.78%	23
2020 Q1	$2.38M	Sell	31,273 -5,682	-15%	-$484K	1.81%	23
2019 Q4	$3.27M	Sell	36,955 -10,278	-22%	-$853K	2.14%	17
2019 Q3	$3.58M	Sell	47,233 -4,183	-8%	-$287K	2.3%	10
2019 Q2	$3.74M	Buy	+51,416	New	+$4.04M	2%	11
2017 Q4	–	Sell	-2,350	Closed	-$209K	–	84
2017 Q3	$209K	Buy	+2,350	New	+$179K	0.13%	70
2017 Q2	–	Sell	-3,650	Closed	-$238K	–	69
2017 Q1	$238K	Buy	+3,650	New	+$229K	0.13%	61
2016 Q2	–	Sell	-4,875	Closed	-$278K	–	74
2016 Q1	$278K	Buy	4,875 +275	+6%	+$15.3K	0.15%	58
2015 Q4	$273K	Buy	+4,600	New	+$265K	0.16%	50

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Vontobel Swiss Wealth Advisors's ABBV Position: Q2 2021 in Review

Vontobel Swiss Wealth Advisors increased its AbbVie (ABBV) stake by 6.1% in Q2 2021, buying an estimated $25.3K and bringing the position to 3,923 shares worth $442K. The position accounts for 0.23% of the portfolio, ranked #54.

Vontobel Swiss Wealth Advisors first reported a position in ABBV in Q4 2015 and has held it in 13 quarters since. The position peaked at $3.74M in Q2 2019. 2,676 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

Vontobel Swiss Wealth Advisors held 3,923 shares of AbbVie worth $442K as of Q2 2021.
Vontobel Swiss Wealth Advisors bought 225 AbbVie shares in Q2 2021, an estimated $25.3K.
AbbVie made up 0.23% of Vontobel Swiss Wealth Advisors's portfolio in Q2 2021, its #54 holding.
Vontobel Swiss Wealth Advisors first reported a position in AbbVie in Q4 2015 and has held it in 13 quarters since.
Vontobel Swiss Wealth Advisors's AbbVie position peaked at $3.74M in Q2 2019.
2,676 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Vontobel Swiss Wealth Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.